Literature DB >> 23786335

Tirofiban-induced acute profound thrombocytopenia: what is the optimal approach to treatment?

Yalcin Velibey1, Yalcin Golcuk, Ahmet Ekmekci, Servet Altay, Erkan Gunay, Mehmet Eren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23786335     DOI： 10.3109/09537104.2013.787406

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  2 in total

1.  The Safety and Efficacy of Continuous Tirofiban as a Monoantiplatelet Therapy in the Management of Ruptured Aneurysms Treated Using Stent-Assisted Coiling or Flow Diversion and Requiring Ventricular Drainage.

Authors:  Kaustubh Limaye; Mario Zanaty; Joseph Hudson; Daichi Nakagawa; Sami Al Kasab; Carlos Alvarez; Sudeepta Dandapat; David K Kung; Santiago Ortega-Gutierrez; Pascal Jabbour; Edgar A Samaniego; David Hasan
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

2.  Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect.

Authors:  Muhammad Shabbir Rawala; Amna Saleem Ahmed; Kanna Posina; Varun Sundaram
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.